Abstract
Bullous pemphigoid (BP) is an autoimmune blistering disorder that presents as tense blister formation on the body (Schmidt and Zillikens, 2013). BP autoantibodies target two hemidesmosomal components in basal keratinocytes: BP180 and BP230 (Schmidt and Zillikens, 2013). In BP, 80‒90% of autoantibodies target the NC16A domain of BP180 (Ishiko et al., 1993). It remains largely unclear why anti-BP180 autoantibodies develop in certain individuals, and there is limited information about the prevalence of anti-BP180 autoantibodies in healthy individuals.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
